1. A prospective epidemiological study of new incident GISTs during two consecutive years in Rhone Alpes region: incidence and molecular distribution of GIST in a European region;Cassier;Br J Cancer,2010
2. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial;DeMatteo;Lancet,2009
3. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial;Joensuu;JAMA,2012
4. 4. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: soft tissue sarcoma. V.2.2012. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. [accessed September 6, 2012].
5. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up;The ESMO/European Sarcoma Network Working Group;Ann Oncol,2012